IP Library › Granted Patent US 7,141,072
Granted Patent B2
US 7,141,072 · App. 09/925,728 · Granted Nov 28, 2006

Method for promoting regeneration of surface cartilage in a damaged joint using multi-layer covering

Assignee: Ed. Geistlich Soehne AG fuer Chemische Industrie
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,141,072
App. No.
09/925,728
Granted
Nov 28, 2006
Kind
B2
Abstract

A method of promoting regeneration of surface cartilage of a joint includes the steps of covering the area to be treated with a patch which includes a sheet of collagen membrane material. The collagen membrane material has at least one barrier layer to prevent passage of cells therethrough. The collagen membrane further includes a matrix layer predominantly of collagen II having an open sponge-like texture. The patch is fixed over the area to be treated, and the area is allowed to regenerate cartilage.

Claims (23)

1. A method of promoting regeneration of surface cartilage of a joint, comprising:

covering an area of damaged cartilage of a joint to be treated with a patch consisting essentially of a multi layer sheet of collagen membrane material, wherein said multi layer sheet of collagen membrane material is comprised of at least one barrier layer which acts as a barrier to inhibit passage of cells therethrough, wherein said at least one barrier layer has a thickness of about 0.2–2 mm and has a structure consisting essentially of collagen I, collagen III or mixtures thereof, wherein said sheet of collagen membrane material further comprises a matrix layer having a thickness of about 0.2–12 mm and having a matrix structure which consists essentially of collagen II having an open sponge like texture; wherein said barrier layer has at least one smooth face so as to inhibit cell adhesion thereon, said barrier layer further having a fibrous face opposite said smooth face, wherein said matrix layer is adhered to said fibrous face;

fixing the patch over said area with the at least one said barrier layer oriented away from the damaged area, and said matrix layer with a matrix structure consisting essentially of collagen II oriented toward the damaged area wherein said patch is fixed over the damaged area without application of a separate hemostatic barrier layer in said area; and

allowing said area to regenerate cartilage.

2. The method of claim 1 , wherein said barrier layer, said matrix layer or both, are impregnated with glycosaminoglycan.

3. The method of claim 2 , wherein the glycosaminoglycan is hyaluronic acid, chondroitin 6 sulphate, keratin sulphate or dermatan sulphate.

4. The method of claim 1 wherein the patch is fixed over the area to be treated by adhesively bonding the patch to cartilage surrounding said area to be treated.

5. The method of claim 1 wherein the patch is fixed over the area to be treated by suturing the patch to cartilage surrounding said area to be treated.

6. The method of claim 1 wherein said membrane material carries at least one pharmaceutically or biologically active substance or mesenchymal stem cells having ability to differentiate into cells to regenerate cartilage or bone.

7. The method of claim 6 in which the pharmaceutically acfive substance is selected from the group consisting Taurolidine, Taurultam and a mixture thereof.

8. The method of claim 6 in which the pharmaceutically active substance is selected from the group consisting of cell growth promoting hormones, bone morphogenetic proteins (BMPs), other skeletal matrix molecules, and signaling peptides.

9. The method of claim 6 wherein the pharmaceutically active substance is selected from the group consisting of BMP-2, BMP-3, BMP-4, BMP-7, BMP-8, OP-1, PTH, TGF-β, TGF-β1, VEGF, CIP, IGF, PTHrP, PDGF and mixtures thereof.

10. The method of claim 1 wherein said membrane material carries articular cartilage stem cells or bone stem cells.

11. The method of claim 1 wherein said membrane material carries bone marrow stromal cells.

12. The method of claim 1 further comprising implanting a resorbable bone mineral implant material into a region of bone injury in the area to be treated, prior to fixing said patch over said area to be treated.

13. The method of claim 12 , wherein said bone mineral is charged with chondrocytes.

14. The method of claim 1 , wherein said patch is charged with chondrocytes.

15. The method of claim 1 wherein said patch is comprised of a single barrier layer.

16. The method of claim 1 wherein said patch comprises said matrix layer sandwiched between one said barrier layer and a second said barrier layer.

17. The method of claim 1 wherein the matrix layer is provided by collagen II material derived from natural cartilage.

18. The method of claim 17 wherein the collagen II material is derived from hyaline cartilage from pigs.

19. The method of claim 17 wherein the collagen II material is physically cross linked.

20. The method of claim 1 wherein said at least one barrier layer is derived from peritoneum membrane from calves or pigs.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 20, 2001
From: GEISTLICH, PETER; SCHLOESSER, LOTHAR
To: ED. GEISTLICH SOEHNE AG FUER CHEMISCHE INDUSTRIE
Reel/Frame 012183/0776 →
Continuity (3)
Continuation In Part 0954546500
Provisional Application 6022401000 · Aug 10, 2000
Related Publication 20020013627A1 · Jan 31, 2002